Tuesday 26 March 2019

Reuters Health Report: OxyContin maker Purdue agrees to settle Oklahoma opioid case: source

Reuters.com Newsletter

OxyContin maker Purdue agrees to settle Oklahoma opioid case: source

Purdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusing the OxyContin painkiller maker of helping fuel an opioid abuse epidemic, a person familiar with the matter said.

California avocados voluntarily recalled for possible health risk

A California avocado grower and distributor has voluntarily recalled its product from six states due to concerns about possible contamination with Listeria, bacteria that can cause severe illness in some people.

Obamacare enrollments drop marginally for 2019

Enrollments in healthcare plans for 2019 through the Federal Obamacare marketplace dropped marginally by 300,000 from last year, according to U.S. government figures released on Monday.

Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial

Oklahoma's top court on Monday declined to delay a landmark trial set for May in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma LP and two other drugmakers of helping fuel an opioid abuse and overdose epidemic in the state.

Women diagnosed years later than men for same diseases

(Reuters Health) - For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study.

Factbox: Cyclone Idai kills 686, displaces hundreds of thousands

Hundreds of thousands of people are in need of food, water and shelter after Cyclone Idai battered Mozambique, Zimbabwe and Malawi.

Mozambique prepares for cholera after cyclone wreaks havoc

Rescue teams in Mozambique moved hundreds of people displaced by Cyclone Idai's massive and deadly flooding to safer shelters on Monday, while the government made preparations for a cholera outbreak that it says is inevitable amid the devastation.

Tiniest U.S. preemies more likely to end up in lower-quality NICU if they're black

(Reuters Health) - In a large national study that included nearly 90 percent of all preterm and low-birth-weight babies born in the U.S. in a recent three-year period, researchers found that black infants were more likely than white infants to receive care in a lower-scoring neonatal intensive care unit (NICU).

Bayer, J&J settle U.S. Xarelto litigation for $775 million

Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.

Bill Gates urges Afghanistan and Pakistan to 'get to zero' in polio fight

Local Afghan Taliban leaders are hindering global efforts to end polio, but Afghanistan and Pakistan must continue their fight to "get to zero" cases, the philanthropist Bill Gates said on Monday.

Early test of male birth control pill shows no safety problems

(Reuters Health) - After taking an experimental male birth control pill for 28 days, 30 men reported no serious side effects and the drug showed signs of decreasing sperm production, according to results of a phase 1 safety test reported Sunday in a poster session at ENDO 2019, the Endocrine Society's annual meeting in New Orleans.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS